This is the Weight and Healthcare newsletter! If you like what you are reading, please consider subscribing and/or sharing! In Part 1 we talked about how Novo Nordisk got suspended from The Association of the British Pharmaceutical Industry for their shady marketing practices. Today, we’re going to talk about an investigation by The Observer that found what so many of us have been saying for a looooong time - that Novo Nordisk had paid millions to prominent ob*sity “charities,” NHS trusts, universities and other bodies as well healthcare professionals who publicly praised the drug (typically without disclosure of their funding) and who advised NICE (The National Institute for Health and Care Excellence) on their reviewing of Novo’s weight loss drug to decide whether or not it should be made available.
came here to check you'd seen this article! so enraging 🤬 I didn't know about the price gouging insulin thing - do you have an article or anything with more information? not that I disbelieve you, I'm just collecting ammunition for when my GP inevitably tries to prescribe me this shit
"The report contained graphs showing how Novo has raised the price on its rapid-acting insulin Novolog by 628% since 2001 by hiking the price 28 times. The price hikes happened in almost perfect lockstep with rival Eli Lilly's Humalog insulin product.
Similarly, Novo raised its prices for its long-acting insulin Levemir drug 18 times, by a total of 360% between 2006 and 2019. This happened in tandem with Sanofi's price hikes on its Lantus product."
came here to check you'd seen this article! so enraging 🤬 I didn't know about the price gouging insulin thing - do you have an article or anything with more information? not that I disbelieve you, I'm just collecting ammunition for when my GP inevitably tries to prescribe me this shit
"The report contained graphs showing how Novo has raised the price on its rapid-acting insulin Novolog by 628% since 2001 by hiking the price 28 times. The price hikes happened in almost perfect lockstep with rival Eli Lilly's Humalog insulin product.
Similarly, Novo raised its prices for its long-acting insulin Levemir drug 18 times, by a total of 360% between 2006 and 2019. This happened in tandem with Sanofi's price hikes on its Lantus product."
https://www.webull.com/news/48694965
thank you so much, that's horrible but of course they would manufacture a diabetes crisis just before introducing a new magical cure 🤦♀️
Disgusting!!
Thanks again for sharing this with us Ragen. Sickening behavior- in every sense of the word!